DA-5212
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DA-5212, covering 2024-12-13 to 2024-12-13. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of DA-5212 in Patients with Functional Dyspepsia [Phase 3]